Saudi Food and Drug Authority launches 'Nader' program to speed up rare disease drug approvals
The Saudi Food and Drug Authority has unveiled the 'Nader' program to accelerate the development and licensing of rare disease medicines.
We haven't written up this one. Ajel English has the full story — the link below goes straight to it.